← All trials
NCT05844956
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2022
- Primary completion
- Apr 30, 2027
- Completion date
- Oct 30, 2027
- First posted
- May 6, 2023
- Last posted
- May 9, 2023
- Enrollment
- 386
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.Lead sponsor
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.